Novel targets for prostate cancer immunotherapy

Prostate Cancer ◽

10.1201/b14450-42 ◽

2005 ◽

pp. 405-416

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy ◽

Download Full-text

HLA-A2-restricted Cytotoxic T Lymphocyte Epitopes from Human Hepsin as Novel Targets for Prostate Cancer Immunotherapy

Scandinavian Journal of Immunology ◽

10.1111/sji.12083 ◽

2013 ◽

Vol 78 (3) ◽

pp. 248-257 ◽

Author(s):

J. Guo ◽

G. Li ◽

J. Tang ◽

X.-B. Cao ◽

Q.-Y. Zhou ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy ◽

T Lymphocyte ◽

Cytotoxic T Lymphocyte ◽

Download Full-text

Development of Artificial Antigen Presenting Cells for Prostate Cancer Immunotherapy

10.21236/ada482123 ◽

2007 ◽

Author(s):

Jonathan P. Schneck ◽

Mathias Oelke

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy ◽

Antigen Presenting Cells ◽

Artificial Antigen ◽

Antigen Presenting

Download Full-text

T-Pharmacytes for Prostate Cancer Immunotherapy

10.21236/ada563801 ◽

2012 ◽

Author(s):

Jianzhu Chen

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy

Download Full-text

Editorial: Prostate Cancer Immunotherapy

Current Cancer Therapy Reviews ◽

10.2174/1573394711208040237 ◽

2012 ◽

Vol 8 (4) ◽

pp. 237-237

Author(s):

Dr. Dev Karan ◽

Peter Van Veldhuizen

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy

Download Full-text

Exploring novel targets for CAR-T therapy for prostate cancer

Cytotherapy ◽

10.1016/j.jcyt.2019.04.057 ◽

2019 ◽

Vol 21 (5) ◽

pp. e15-e16

Author(s):

J. Zhu ◽

D. Meyran ◽

J. Butler ◽

D. Tantalo ◽

M. Neeson ◽

...

Keyword(s):

Prostate Cancer ◽

Car T ◽

Download Full-text

Is there still an open window in metastatic castration resistant prostate cancer immunotherapy horizon?

Translational Cancer Research ◽

10.21037/tcr.2016.11.05 ◽

2016 ◽

Vol 5 (S6) ◽

pp. S1061-S1065

Author(s):

Chiara Ciccarese ◽

Giampaolo Tortora ◽

Rodolfo Montironi ◽

Francesco Massari

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Download Full-text

A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness

10.18632/oncotarget.5291 ◽

2015 ◽

Vol 6 (32) ◽

pp. 33253-33268 ◽

Author(s):

David Cheishvili ◽

Barbara Stefanska ◽

Cao Yi ◽

Chen Chen Li ◽

Patricia Yu ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Cell ◽

Prostate Cancer Cell ◽

Cancer Cell Lines ◽

Prostate Cancer Cell Lines ◽

Cancer Invasiveness ◽

Download Full-text

Prostate Cancer Immunotherapy: Figure 1.

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-10-3402 ◽

2011 ◽

Vol 17 (16) ◽

pp. 5233-5238 ◽

Author(s):

Kenneth F. May ◽

James L. Gulley ◽

Charles G. Drake ◽

Glenn Dranoff ◽

Philip W. Kantoff

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy

Download Full-text

Emerging treatments for metastatic castration-resistant prostate cancer: Immunotherapy, PARP inhibitors, and PSMA-targeted approaches

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2020.100164 ◽

2020 ◽

Vol 23 ◽

pp. 100164 ◽

Author(s):

Catherine Handy Marshall ◽

Emmanuel S. Antonarakis

Keyword(s):

Prostate Cancer ◽

Cancer Immunotherapy ◽

Parp Inhibitors ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Emerging Treatments

Download Full-text

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy

Cancer Immunology Immunotherapy ◽

10.1007/s00262-020-02480-4 ◽

2020 ◽

Vol 69 (3) ◽

pp. 449-463 ◽

Author(s):

Remy Thomas ◽

Hibah Shaath ◽

Adviti Naik ◽

Salman M. Toor ◽

Eyad Elkord ◽

...

Keyword(s):

Lactate Dehydrogenase ◽

Cancer Immunotherapy ◽

Lactate Dehydrogenase C ◽

Download Full-text